The Department of Oncology is continuously working to offer clinical trials to all patient groups receiving treatment with us.
Talk to us about clinical trials at: ClinicalTrials.Oncology@ahus.no
The Department of Oncology is responsible for approximately 594,000 residents, equivalent to 10 percent of Norway’s population. We conduct more than 29,000 outpatient consultations annually.
Read more about how we conduct clinical trials in the timeline at the bottom of this page.
We are always looking for new collaborations and partners.
If you would like to conduct a feasibility assessment or have other inquiries, please email us at:
ClinicalTrials.Oncology@ahus.no
We typically respond within five business days.
We receive inquiries about new clinical trials via email: ClinicalTrials.Oncology@ahus.no
Requests are typically answered within five business days.
We are committed to ensuring timely and well-coordinated validation visits.
We can assist in preparing key documents such as the patient information and consent forms. To simplify the process, the Norwegian authorities have developed templates that meet national regulatory requirements: Templates – Rekportalen.
Once the regulatory applications have been submitted, our Data Protection Officer can begin reviewing the clinical trial in a parallel process.
All clinical trials initiated by the pharmaceutical industry must be reported to Inven2, which acts as a third party in negotiations regarding budgets, contracts, and payments related to clinical trials within the health region to which Ahus belongs.
For more information, visit: Industry Information – Inven2
Academic studies generally do not need to be reported to Inven2. Please contact us if you are unsure whether your study should be registered.
We facilitate close communication between the Study Site and the Sponsor to ensure activation is achieved as quickly as possible. Typically, all key personnel will participate in the study initiation visit.
We work as efficiently as possible to reach the assigned number of patients included in each clinical trial. Financial follow-up is conducted twice a year (March and October) via Inven2 for clinical trials commissioned by the pharmaceutical industry.
For more information, visit: Industry Information – Inven2
Academic studies that are not registered with Inven2 are followed up financially according to project-specific agreements.
Our continuous monitoring of electronic data capture systems, including ongoing data entry and resolution of queries and comments, contributes to an efficient closure of the clinical trial.
The Investigator Site File (ISF) is maintained and updated throughout the course of the study and, upon study completion, is prepared for long-term archiving in accordance with applicable regulations.